MEMANTINE Drug Patent Profile
✉ Email this page to a colleague
When do Memantine patents expire, and what generic alternatives are available?
Memantine is a drug marketed by Amneal Pharms, Ani Pharms, Apotex, Aurobindo Pharma Ltd, Lupin Ltd, Macleods Pharms Ltd, Ph Health, Rising, Sun Pharm, Vitruvias, Yichang Humanwell, Zydus Pharms, Chartwell Molecular, Medley Pharms, Sciegen Pharms, Ajanta Pharma Ltd, Alembic, Chartwell, Dr Reddys Labs Ltd, Hetero Labs Ltd V, Hikma, Jubilant Generics, Lannett Co Inc, Orbion Pharms, Pointview Hldings, Puracap Labs Blu, Puracap Pharm Llc, Renata, Strides Pharma, Teva Pharms, Torrent, Unichem, Upsher Smith Labs, Yiling, Zydus Lifesciences, Amneal, and Xiamen Lp Pharm Co. and is included in forty-seven NDAs.
The generic ingredient in MEMANTINE is donepezil hydrochloride; memantine hydrochloride. There are thirty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride; memantine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEMANTINE?
- What are the global sales for MEMANTINE?
- What is Average Wholesale Price for MEMANTINE?
Summary for MEMANTINE
| US Patents: | 0 |
| Applicants: | 37 |
| NDAs: | 47 |
| Drug Prices: | Drug price information for MEMANTINE |
| Drug Sales Revenues: | Drug sales revenues for MEMANTINE |
| DailyMed Link: | MEMANTINE at DailyMed |
US Patents and Regulatory Information for MEMANTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett Co Inc | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 207236-001 | Nov 10, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Upsher Smith Labs | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 090043-002 | Jul 31, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Yichang Humanwell | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211100-001 | Apr 2, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 206032-004 | Sep 28, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Renata | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 209527-001 | May 7, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
